{"version":"1.0","type":"link","title":"Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing.","author_name":"Oehler VG 외","author_url":"https://prs-insight.online/author/Oehler%20VG","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160281","thumbnail_width":1200,"thumbnail_height":630}